Trinity Biotech Acquires 12.5% Stake in Novus Diagnostics Valued at $2.5M

TipRanksOct 25 08:56 ET

Express News | Trinity Biotech Shares Are Trading Higher After the Company Announced the Acquisition of EpiCapture. Also the Company Announced a Strategic Investment in Novus Diagnostics to Advance Development and Commercialization of Novus' Point-of-care Diagnostic...

BenzingaOct 25 08:47 ET

Trinity Biotech Announces Acquisition Of Prostate Cancer Focused EpiCapture For Initial Consideration Of ~$3M, With An Additional Consideration Of $0.5M Contingent On The Achievement Of Future Milestones

BenzingaOct 25 08:47 ET

Trinity Biotech Enters Oncology Space With Acquisition Of Prostate Cancer Focused EpiCapture >TRIB

Dow JonesOct 25 08:45 ET

Express News | Trinity Biotech Enters Oncology Space With Acquisition of Prostate Cancer Focused Epicapture

ReutersOct 25 08:45 ET

Express News | Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

ReutersOct 25 08:45 ET